Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIICompletedD-0208-2025

Drug recall · January 29, 2025

Venlafaxine Extended-Release Tablets recall

Why: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Lots / codes

Lot #: 2402101UR, Exp 02/28/2027

Quantity
1380 bottles
Company
Appco Pharma LLC, Piscataway, NJ
Distribution
Nationwide USA.
Initiated
January 16, 2025 · Voluntary: Firm initiated
Classified
January 23, 2025
Reported
January 29, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Venlafaxine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.